Literature DB >> 8456726

Postinfectious encephalopathy in a child following Campylobacter jejuni enteritis.

C A Nasralla1, N Pay, H C Goodpasture, J J Lin, W B Svoboda.   

Abstract

We report a case of acute postinfectious encephalopathy in a child following Campylobacter jejuni enteritis. Serial MR scans showed lesions involving predominantly gray matter and the adjacent subcortical white matter--findings different from those in other immune-mediated disorders, such as systemic lupus erythematosus, in which either white or gray matter may be involved, and acute disseminated encephalomyelitis, in which white matter abnormalities predominate with involvement of the subcortical white matter.

Entities:  

Mesh:

Year:  1993        PMID: 8456726      PMCID: PMC8332966     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  5 in total

1.  MRI of encephalitis in children: comparison of CT and MRI in the acute stage with long-term follow-up.

Authors:  W Koelfen; M Freund; F Gückel; H Rohr; C Schultze
Journal:  Neuroradiology       Date:  1996-01       Impact factor: 2.804

2.  Acute encephalopathy associated with Campylobacter jejuni enteritis.

Authors:  Dragan Lepur; Vjerislav Peterković; Sanja Belak Kovačević; Klaudija Višković; Nevija Kalabrić Lepur; Marko Kutleša
Journal:  Neurol Sci       Date:  2011-05-10       Impact factor: 3.830

3.  Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope.

Authors:  N Yuki; T Taki; M Takahashi; K Saito; T Tai; T Miyatake; S Handa
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 4.  Acuted disseminated encephalomyelitis.

Authors:  Joy B Parrish; E Ann Yeh
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 5.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.